{
    "PMC5564609_3": [
        {
            "subject": {
                "Parameter": "Delayed gastric emptying",
                "Group": "ERAS",
                "n": "76",
                "Value": "15"
            },
            "measures": "[Value]",
            "outcomes": "[15]"
        },
        {
            "subject": {
                "Parameter": "Delayed gastric emptying",
                "Group": "Conventional",
                "n": "83",
                "Value": "32"
            },
            "measures": "[Value]",
            "outcomes": "[32]"
        },
        {
            "subject": {
                "Parameter": "Delayed gastric emptying",
                "P": "0.02"
            },
            "measures": "[P]",
            "outcomes": "[0.02]"
        },
        {
            "subject": {
                "Parameter": "Bleeding",
                "Group": "ERAS",
                "n": "76",
                "Value": "6"
            },
            "measures": "[Value]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Parameter": "Bleeding",
                "Group": "Conventional",
                "n": "83",
                "Value": "4"
            },
            "measures": "[Value]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "Parameter": "Bleeding",
                "P": "0.5"
            },
            "measures": "[P]",
            "outcomes": "[0.5]"
        },
        {
            "subject": {
                "Parameter": "Pancreatic fistula",
                "Group": "ERAS",
                "n": "76",
                "Value": "39"
            },
            "measures": "[Value]",
            "outcomes": "[39]"
        },
        {
            "subject": {
                "Parameter": "Pancreatic fistula",
                "Group": "Conventional",
                "n": "83",
                "Value": "36"
            },
            "measures": "[Value]",
            "outcomes": "[36]"
        },
        {
            "subject": {
                "Parameter": "Pancreatic fistula",
                "P": "0.52"
            },
            "measures": "[P]",
            "outcomes": "[0.52]"
        },
        {
            "subject": {
                "Parameter": "Grade A",
                "Group": "ERAS",
                "n": "76",
                "Value": "8"
            },
            "measures": "[Value]",
            "outcomes": "[8]"
        },
        {
            "subject": {
                "Parameter": "Grade A",
                "Group": "Conventional",
                "n": "83",
                "Value": "6"
            },
            "measures": "[Value]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Parameter": "Grade B",
                "Group": "ERAS",
                "n": "76",
                "Value": "10"
            },
            "measures": "[Value]",
            "outcomes": "[10]"
        },
        {
            "subject": {
                "Parameter": "Grade B",
                "Group": "Conventional",
                "n": "83",
                "Value": "6"
            },
            "measures": "[Value]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Parameter": "Grade C",
                "Group": "ERAS",
                "n": "76",
                "Value": "21"
            },
            "measures": "[Value]",
            "outcomes": "[21]"
        },
        {
            "subject": {
                "Parameter": "Grade C",
                "Group": "Conventional",
                "n": "83",
                "Value": "24"
            },
            "measures": "[Value]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "Parameter": "Biliary fistula",
                "Group": "ERAS",
                "n": "76",
                "Value": "2"
            },
            "measures": "[Value]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "Parameter": "Biliary fistula",
                "Group": "Conventional",
                "n": "83",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Biliary fistula",
                "P": "0.47"
            },
            "measures": "[P]",
            "outcomes": "[0.47]"
        },
        {
            "subject": {
                "Parameter": "Wound infection",
                "Group": "ERAS",
                "n": "76",
                "Value": "5"
            },
            "measures": "[Value]",
            "outcomes": "[5]"
        },
        {
            "subject": {
                "Parameter": "Wound infection",
                "Group": "Conventional",
                "n": "83",
                "Value": "3"
            },
            "measures": "[Value]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "Parameter": "Wound infection",
                "P": "0.66"
            },
            "measures": "[P]",
            "outcomes": "[0.66]"
        },
        {
            "subject": {
                "Parameter": "Pulmonary complication",
                "Group": "ERAS",
                "n": "76",
                "Value": "2"
            },
            "measures": "[Value]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "Parameter": "Pulmonary complication",
                "Group": "Conventional",
                "n": "83",
                "Value": "4"
            },
            "measures": "[Value]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "Parameter": "Pulmonary complication",
                "P": "0.1"
            },
            "measures": "[P]",
            "outcomes": "[0.1]"
        },
        {
            "subject": {
                "Parameter": "Skin orifice infection",
                "Group": "ERAS",
                "n": "76",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Skin orifice infection",
                "Group": "Conventional",
                "n": "83",
                "Value": "6"
            },
            "measures": "[Value]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Parameter": "Skin orifice infection",
                "P": "0.012"
            },
            "measures": "[P]",
            "outcomes": "[0.012]"
        },
        {
            "subject": {
                "Parameter": "Abdominal abscess",
                "Group": "ERAS",
                "n": "76",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Abdominal abscess",
                "Group": "Conventional",
                "n": "83",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Pancreatitis",
                "Group": "ERAS",
                "n": "76",
                "Value": "2"
            },
            "measures": "[Value]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "Parameter": "Pancreatitis",
                "Group": "Conventional",
                "n": "83",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Pancreatitis",
                "P": "1"
            },
            "measures": "[P]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Sepsis",
                "Group": "ERAS",
                "n": "76",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Sepsis",
                "Group": "Conventional",
                "n": "83",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Sepsis",
                "P": "1"
            },
            "measures": "[P]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Re-laparotomy",
                "Group": "ERAS",
                "n": "76",
                "Value": "3"
            },
            "measures": "[Value]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "Parameter": "Re-laparotomy",
                "Group": "Conventional",
                "n": "83",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Re-laparotomy",
                "P": "0.6"
            },
            "measures": "[P]",
            "outcomes": "[0.6]"
        },
        {
            "subject": {
                "Parameter": "Mortality",
                "Group": "ERAS",
                "n": "76",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Mortality",
                "Group": "Conventional",
                "n": "83",
                "Value": "0"
            },
            "measures": "[Value]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Parameter": "Readmission (in 30 days)",
                "Group": "ERAS",
                "n": "76",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Readmission (in 30 days)",
                "Group": "Conventional",
                "n": "83",
                "Value": "1"
            },
            "measures": "[Value]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Parameter": "Readmission (in 30 days)",
                "P": "1"
            },
            "measures": "[P]",
            "outcomes": "[1]"
        }
    ],
    "PMC3798558_1": [
        {
            "subject": {
                "study type": "case-control",
                "disease": "pancreatic cancer",
                "comparison group": "non-cancer controls"
            },
            "measures": "[P-value]",
            "outcomes": "[0.999]"
        }
    ],
    "PMC5762325_3": [
        {
            "subject": {
                "Tumor tissue sample": "E-cadherin Low",
                "STYK1": "Low and High",
                "Correlation coefficient": "-0.420",
                "P-value": "<0.001"
            },
            "measures": "[Correlation coefficient, P-value]",
            "outcomes": "[-0.420, <0.001]"
        },
        {
            "subject": {
                "Tumor tissue sample": "E-cadherin High",
                "STYK1": "Low and High"
            },
            "measures": "[None]",
            "outcomes": "[None]"
        }
    ],
    "PMC3798558_3": [
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "1",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.439",
                "Haplotype frequency cases": "0.433",
                "Haplotype frequency controls": "0.442",
                "Adjusted OR": "1.00 (ref.)"
            },
            "measures": "[Adjusted OR]",
            "outcomes": "[1.00 (ref.)]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "1",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.439",
                "Haplotype frequency cases": "0.433",
                "Haplotype frequency controls": "0.442",
                "P-value": ""
            },
            "measures": "[P-value]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "2",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.240",
                "Haplotype frequency cases": "0.274",
                "Haplotype frequency controls": "0.239",
                "Adjusted OR": "1.32 (1.01-1.71)"
            },
            "measures": "[Adjusted OR]",
            "outcomes": "[1.32 (1.01-1.71)]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "2",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.240",
                "Haplotype frequency cases": "0.274",
                "Haplotype frequency controls": "0.239",
                "P-value": "0.042"
            },
            "measures": "[P-value]",
            "outcomes": "[0.042]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "3",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.319",
                "Haplotype frequency cases": "0.292",
                "Haplotype frequency controls": "0.318",
                "Adjusted OR": "1.05 (0.81-1.36)"
            },
            "measures": "[Adjusted OR]",
            "outcomes": "[1.05 (0.81-1.36)]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "3",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.319",
                "Haplotype frequency cases": "0.292",
                "Haplotype frequency controls": "0.318",
                "P-value": "0.691"
            },
            "measures": "[P-value]",
            "outcomes": "[0.691]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "4",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.002",
                "Haplotype frequency cases": "<0.001",
                "Haplotype frequency controls": "0.002",
                "Adjusted OR": "N.E."
            },
            "measures": "[Adjusted OR]",
            "outcomes": "[N.E.]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "Haplotype": "4",
                "SNP 1": "rs1799782 (C>T)",
                "SNP 2": "rs25487 (G>A)",
                "Haplotype frequency": "0.002",
                "Haplotype frequency cases": "<0.001",
                "Haplotype frequency controls": "0.002",
                "P-value": "N.E."
            },
            "measures": "[P-value]",
            "outcomes": "[N.E.]"
        },
        {
            "subject": {
                "Gene": "XRCC1",
                "R-squared": "0.15",
                "SNP 1": "rs1799782",
                "SNP 2": "rs25487"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Study type": "case-control",
                "Analysis": "haplotype-effects logistic regression",
                "Adjustment": "multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC4423458_3": [
        {
            "subject": {
                "Protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "Accession": "70906435",
                "MW (kDa)": "56",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[2.2]"
        },
        {
            "subject": {
                "Average SC": "52.1"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[2.2]"
        },
        {
            "subject": {
                "NSAF ratio": "2.2",
                "_P_-value (_t_-test)": "0.01481"
            }
        },
        {
            "subject": {
                "Protein": "C4b-binding protein alpha chain precursor",
                "Accession": "4502503",
                "MW (kDa)": "67",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[2.3]"
        },
        {
            "subject": {
                "Average SC": "11.5"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[2.3]"
        },
        {
            "subject": {
                "NSAF ratio": "2.3",
                "_P_-value (_t_-test)": "0.04311"
            }
        },
        {
            "subject": {
                "Protein": "Serum albumin pre-pro-protein",
                "Accession": "4502027",
                "MW (kDa)": "69",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[2.4]"
        },
        {
            "subject": {
                "Average SC": "332.8"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[2.4]"
        },
        {
            "subject": {
                "NSAF ratio": "2.4",
                "_P_-value (_t_-test)": "0.00006"
            }
        },
        {
            "subject": {
                "Protein": "Vitamin D-binding protein isoform 1 precursor",
                "Accession": "32483410",
                "MW (kDa)": "53",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[2.4]"
        },
        {
            "subject": {
                "Average SC": "19.2"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[2.4]"
        },
        {
            "subject": {
                "NSAF ratio": "2.4",
                "_P_-value (_t_-test)": "0.03919"
            }
        },
        {
            "subject": {
                "Protein": "Kininogen-1 isoform 2 precursor",
                "Accession": "4504893",
                "MW (kDa)": "48",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[3.8]"
        },
        {
            "subject": {
                "Average SC": "5.5"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[3.8]"
        },
        {
            "subject": {
                "NSAF ratio": "3.8",
                "_P_-value (_t_-test)": "0.01109"
            }
        },
        {
            "subject": {
                "Protein": "Alpha-2-macroglobulin precursor",
                "Accession": "66932947",
                "MW (kDa)": "163",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[3.9]"
        },
        {
            "subject": {
                "Average SC": "29.3"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[3.9]"
        },
        {
            "subject": {
                "NSAF ratio": "3.9",
                "_P_-value (_t_-test)": "0.00618"
            }
        },
        {
            "subject": {
                "Protein": "Haptoglobin isoform 1 pre-pro-protein",
                "Accession": "4826762",
                "MW (kDa)": "45",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[4.2]"
        },
        {
            "subject": {
                "Average SC": "18.0"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[4.2]"
        },
        {
            "subject": {
                "NSAF ratio": "4.2",
                "_P_-value (_t_-test)": "0.00024"
            }
        },
        {
            "subject": {
                "Protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "Accession": "70906439",
                "MW (kDa)": "52",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[4.3]"
        },
        {
            "subject": {
                "Average SC": "17.3"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[4.3]"
        },
        {
            "subject": {
                "NSAF ratio": "4.3",
                "_P_-value (_t_-test)": "0.00133"
            }
        },
        {
            "subject": {
                "Protein": "Complement C3 precursor",
                "Accession": "115298678",
                "MW (kDa)": "187",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[4.3]"
        },
        {
            "subject": {
                "Average SC": "35.6"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[4.3]"
        },
        {
            "subject": {
                "NSAF ratio": "4.3",
                "_P_-value (_t_-test)": "0.00612"
            }
        },
        {
            "subject": {
                "Protein": "Myeloperoxidase precursor",
                "Accession": "4557759",
                "MW (kDa)": "84",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[5.3]"
        },
        {
            "subject": {
                "Average SC": "11.0"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[5.3]"
        },
        {
            "subject": {
                "NSAF ratio": "5.3",
                "_P_-value (_t_-test)": "0.02501"
            }
        },
        {
            "subject": {
                "Protein": "Apolipoprotein A-I pre-pro-protein",
                "Accession": "4557321",
                "MW (kDa)": "31",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[5.7]"
        },
        {
            "subject": {
                "Average SC": "5.9"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[5.7]"
        },
        {
            "subject": {
                "NSAF ratio": "5.7",
                "_P_-value (_t_-test)": "0.02170"
            }
        },
        {
            "subject": {
                "Protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "Accession": "4503689",
                "MW (kDa)": "95",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[6.4]"
        },
        {
            "subject": {
                "Average SC": "9.3"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[6.4]"
        },
        {
            "subject": {
                "NSAF ratio": "6.4",
                "_P_-value (_t_-test)": "0.00031"
            }
        },
        {
            "subject": {
                "Protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "Accession": "156523970",
                "MW (kDa)": "39",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[6.5]"
        },
        {
            "subject": {
                "Average SC": "1.1"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[6.5]"
        },
        {
            "subject": {
                "NSAF ratio": "6.5",
                "_P_-value (_t_-test)": "0.00173"
            }
        },
        {
            "subject": {
                "Protein": "Ceruloplasmin precursor",
                "Accession": "4557485",
                "MW (kDa)": "122",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[7.5]"
        },
        {
            "subject": {
                "Average SC": "5.6"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[7.5]"
        },
        {
            "subject": {
                "NSAF ratio": "7.5",
                "_P_-value (_t_-test)": "0.00114"
            }
        },
        {
            "subject": {
                "Protein": "PREDICTED: complement C4-A isoform 1",
                "Accession": "341916194",
                "MW (kDa)": "193",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[7.7]"
        },
        {
            "subject": {
                "Average SC": "4.5"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[7.7]"
        },
        {
            "subject": {
                "NSAF ratio": "7.7",
                "_P_-value (_t_-test)": "0.01791"
            }
        },
        {
            "subject": {
                "Protein": "Alpha-1B-glycoprotein precursor",
                "Accession": "21071030",
                "MW (kDa)": "54",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[8.3]"
        },
        {
            "subject": {
                "Average SC": "1.2"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[8.3]"
        },
        {
            "subject": {
                "NSAF ratio": "8.3",
                "_P_-value (_t_-test)": "0.00468"
            }
        },
        {
            "subject": {
                "Protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                "Accession": "31542984",
                "MW (kDa)": "103",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[35.4]"
        },
        {
            "subject": {
                "Average SC": "0.2"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[35.4]"
        },
        {
            "subject": {
                "NSAF ratio": "35.4",
                "_P_-value (_t_-test)": "0.00484"
            }
        },
        {
            "subject": {
                "Protein": "Apolipoprotein B-100 precursor",
                "Accession": "105990532",
                "MW (kDa)": "516",
                "Condition": "Control"
            },
            "measures": "[Average SC]",
            "outcomes": "[55.7]"
        },
        {
            "subject": {
                "Average SC": "1.0"
            },
            "measures": "[NSAF ratio]",
            "outcomes": "[55.7]"
        },
        {
            "subject": {
                "NSAF ratio": "55.7",
                "_P_-value (_t_-test)": "0.02595"
            }
        }
    ],
    "PMC5589562_2": [
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-145-5p",
                "Accession no.": "MIMAT0000437",
                "Ratio": "8980.05"
            },
            "measures": "[Ratio]",
            "outcomes": "[8980.05]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199a-5p",
                "Accession no.": "MIMAT0000231",
                "Ratio": "1563.68"
            },
            "measures": "[Ratio]",
            "outcomes": "[1563.68]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199b-5p",
                "Accession no.": "MIMAT0000263",
                "Ratio": "296.31"
            },
            "measures": "[Ratio]",
            "outcomes": "[296.31]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-136-5p",
                "Accession no.": "MIMAT0000448",
                "Ratio": "228.24"
            },
            "measures": "[Ratio]",
            "outcomes": "[228.24]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-137",
                "Accession no.": "MIMAT0000429",
                "Ratio": "227.70"
            },
            "measures": "[Ratio]",
            "outcomes": "[227.70]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-139-5p",
                "Accession no.": "MIMAT0000250",
                "Ratio": "216.83"
            },
            "measures": "[Ratio]",
            "outcomes": "[216.83]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-127-3p",
                "Accession no.": "MIMAT0000446",
                "Ratio": "159.72"
            },
            "measures": "[Ratio]",
            "outcomes": "[159.72]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-337-5p",
                "Accession no.": "MIMAT0004695",
                "Ratio": "148.57"
            },
            "measures": "[Ratio]",
            "outcomes": "[148.57]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-139-3p",
                "Accession no.": "MIMAT0004552",
                "Ratio": "146.36"
            },
            "measures": "[Ratio]",
            "outcomes": "[146.36]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-487b",
                "Accession no.": "MIMAT0003180",
                "Ratio": "118.72"
            },
            "measures": "[Ratio]",
            "outcomes": "[118.72]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                "Accession no.": "MIMAT0000232",
                "Ratio": "107.49"
            },
            "measures": "[Ratio]",
            "outcomes": "[107.49]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-1233",
                "Accession no.": "MIMAT0005588",
                "Ratio": "66.04"
            },
            "measures": "[Ratio]",
            "outcomes": "[66.04]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-379-5p",
                "Accession no.": "MIMAT0000733",
                "Ratio": "62.89"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.89]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-660-5p",
                "Accession no.": "MIMAT0003338",
                "Ratio": "62.50"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.50]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-335-5p",
                "Accession no.": "MIMAT0000765",
                "Ratio": "60.53"
            },
            "measures": "[Ratio]",
            "outcomes": "[60.53]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-205-5p",
                "Accession no.": "MIMAT0000266",
                "Ratio": "23077.19"
            },
            "measures": "[Ratio]",
            "outcomes": "[23077.19]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200c-3p",
                "Accession no.": "MIMAT0000617",
                "Ratio": "5968.64"
            },
            "measures": "[Ratio]",
            "outcomes": "[5968.64]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200b-3p",
                "Accession no.": "MIMAT0000318",
                "Ratio": "467.15"
            },
            "measures": "[Ratio]",
            "outcomes": "[467.15]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-429",
                "Accession no.": "MIMAT0001536",
                "Ratio": "171.07"
            },
            "measures": "[Ratio]",
            "outcomes": "[171.07]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-196b-5p",
                "Accession no.": "MIMAT0001080",
                "Ratio": "116.42"
            },
            "measures": "[Ratio]",
            "outcomes": "[116.42]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-582-5p",
                "Accession no.": "MIMAT0003247",
                "Ratio": "99.53"
            },
            "measures": "[Ratio]",
            "outcomes": "[99.53]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-135b-5p",
                "Accession no.": "MIMAT0000758",
                "Ratio": "87.82"
            },
            "measures": "[Ratio]",
            "outcomes": "[87.82]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-182-5p",
                "Accession no.": "MIMAT0000259",
                "Ratio": "55.81"
            },
            "measures": "[Ratio]",
            "outcomes": "[55.81]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-96-5p",
                "Accession no.": "MIMAT0000095",
                "Ratio": "53.82"
            },
            "measures": "[Ratio]",
            "outcomes": "[53.82]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200a-3p",
                "Accession no.": "MIMAT0000682",
                "Ratio": "44.88"
            },
            "measures": "[Ratio]",
            "outcomes": "[44.88]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-4284",
                "Accession no.": "MIMAT0016915",
                "Ratio": "41.90"
            },
            "measures": "[Ratio]",
            "outcomes": "[41.90]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-345-5p",
                "Accession no.": "MIMAT0000772",
                "Ratio": "27.99"
            },
            "measures": "[Ratio]",
            "outcomes": "[27.99]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-378g",
                "Accession no.": "MIMAT0018937",
                "Ratio": "25.01"
            },
            "measures": "[Ratio]",
            "outcomes": "[25.01]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-203",
                "Accession no.": "MIMAT0000264",
                "Ratio": "22.43"
            },
            "measures": "[Ratio]",
            "outcomes": "[22.43]"
        },
        {
            "subject": {
                "study": "this study",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-141-3p",
                "Accession no.": "MIMAT0000432",
                "Ratio": "21.69"
            },
            "measures": "[Ratio]",
            "outcomes": "[21.69]"
        }
    ],
    "PMC4190529_6": [
        {
            "subject": {
                "Treatment": "gemcitabine",
                "Control": "5-fluorouracil",
                "Phase": "3",
                "Median Survival Therapy": "5.7",
                "Median Survival Control": "4.2",
                "One-Year Survival Therapy": "18%",
                "One-Year Survival Control": "2%",
                "Side Effects": "more favorable than 5-fluorouracil",
                "FDA Approval": "1996"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[5.7, 4.2, 18%, 2%]"
        },
        {
            "subject": {
                "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "Control": "gemcitabine",
                "Phase": "3",
                "Median Survival Therapy": "6.4",
                "Median Survival Control": "6",
                "One-Year Survival Therapy": "24%",
                "One-Year Survival Control": "19%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "2005"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[6.4, 6, 24%, 19%]"
        },
        {
            "subject": {
                "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "Control": "gemcitabine",
                "Phase": "3",
                "Median Survival Therapy": "8.5",
                "Median Survival Control": "6.7",
                "One-Year Survival Therapy": "35%",
                "One-Year Survival Control": "22%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "2013"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[8.5, 6.7, 35%, 22%]"
        },
        {
            "subject": {
                "Treatment": "FOLFIRINOX",
                "Control": "gemcitabine",
                "Phase": "2/3",
                "Median Survival Therapy": "11.1",
                "Median Survival Control": "6.8",
                "One-Year Survival Therapy": "48.4%",
                "One-Year Survival Control": "20.6%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "n/a"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[11.1, 6.8, 48.4%, 20.6%]"
        },
        {
            "subject": {
                "Treatment": "cell encapsulation + ifosfamide",
                "Control": "5-fluorouracil",
                "Phase": "2",
                "Median Survival Therapy": "10",
                "Median Survival Control": "5",
                "One-Year Survival Therapy": "36%",
                "One-Year Survival Control": "18%",
                "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                "FDA Approval": "n/a"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[10, 5, 36%, 18%]"
        },
        {
            "subject": {
                "Treatment": "Oxaliplatin, irinotecan, fluorouracil and leucovorin",
                "Dose": "2 g/m2",
                "NCI Toxicities": "Grade 3 or Grade 4",
                "Median Survival": "9.5 months"
            },
            "measures": "[Median Survival]",
            "outcomes": "[9.5 months]"
        },
        {
            "subject": {
                "Treatment": "cell encapsulation + ifosfamide",
                "Dose": "higher dose",
                "NCI Toxicities": "Grade 3 or Grade 4",
                "Number of Patients": "5"
            },
            "measures": "[Number of Patients]",
            "outcomes": "[5]"
        }
    ],
    "PMC5675623_3": [
        {
            "subject": {
                "Variable": "ECOG performance status",
                "Contrast": "> 0 vs. 0",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.47, 0.12]"
        },
        {
            "subject": {
                "Variable": "Liver metastases",
                "Contrast": "Yes vs. No",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.72, 0.045]"
        },
        {
            "subject": {
                "Variable": "No. of metastatic sites",
                "Contrast": ">2 vs. <= 2",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.33, 0.28]"
        },
        {
            "subject": {
                "Variable": "Prior radiation therapy",
                "Contrast": "Yes vs. No",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.58, 0.077]"
        },
        {
            "subject": {
                "Variable": "Prior FOLFIRINOX",
                "Contrast": "Yes vs. No",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.73, 0.046]"
        },
        {
            "subject": {
                "Variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                "Contrast": "Yes vs. No",
                "Analysis": "multivariate Cox proportional hazards regression analysis",
                "Endpoint": "overall survival (OS)",
                "Treatment": "first phase I treatment"
            },
            "measures": "[Hazard ratio, P value]",
            "outcomes": "[1.08, 0.80]"
        }
    ],
    "PMC4742219_3": [
        {
            "subject": {
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00, 0.874]"
        },
        {
            "subject": {
                "Variable": "Age",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00, 0.874]"
        },
        {
            "subject": {
                "Variable": "Gender",
                "Gender": "female vs. male",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.89, 0.544]"
        },
        {
            "subject": {
                "Variable": "Tumor size",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.13, 0.127]"
        },
        {
            "subject": {
                "Variable": "Tumor grade",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Variable": "Grade II vs. I",
                "Tumor grade": "Grade II vs. I",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00, 0.991]"
        },
        {
            "subject": {
                "Variable": "Grade III vs. I",
                "Tumor grade": "Grade III vs. I",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.93, 0.906]"
        },
        {
            "subject": {
                "Variable": "Lymph Nodes",
                "Lymph Nodes": "yes vs. no",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.39, 0.229]"
        },
        {
            "subject": {
                "Variable": "Margin",
                "Margin": "positive vs. negative",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.54, 0.025]"
        },
        {
            "subject": {
                "Variable": "Vascular invasion",
                "Vascular invasion": "yes vs. no",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[0.99, 0.967]"
        },
        {
            "subject": {
                "Variable": "Perineural invasion",
                "Perineural invasion": "yes vs. no",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[2.19, 0.097]"
        },
        {
            "subject": {
                "Variable": "Time from surgery to first recurrence",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.00, 0.883]"
        },
        {
            "subject": {
                "Variable": "Recurrence pattern",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Variable": "Lung + Other vs. Lung",
                "Recurrence pattern": "Lung + Other vs. Lung",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.25, 0.516]"
        },
        {
            "subject": {
                "Variable": "Liver + Other vs. Lung",
                "Recurrence pattern": "Liver + Other vs. Lung",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[1.91, 0.022]"
        },
        {
            "subject": {
                "Variable": "Peritoneal vs. Lung",
                "Recurrence pattern": "Peritoneal vs. Lung",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[6.32, < 0.001]"
        },
        {
            "subject": {
                "Variable": "Local vs. Lung",
                "Recurrence pattern": "Local vs. Lung",
                "Analysis": "Multivariable",
                "Factor": "Time from recurrence to death",
                "Table": "3"
            },
            "measures": "[HR, P value]",
            "outcomes": "[2.09, 0.025]"
        }
    ],
    "PMC4941379_3": [
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG-/CagA-",
                "Sample": "4555",
                "Cases": "5",
                "Crude incidence rate": "10.42"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[10.42]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA-",
                "Sample": "1984",
                "Cases": "2",
                "Crude incidence rate": "9.54",
                "HR1": "0.79",
                "CI": "0.15-4.08"
            },
            "measures": "[Crude incidence rate, HR1]",
            "outcomes": "[9.54, 0.79]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA+",
                "Sample": "2295",
                "Cases": "14",
                "Crude incidence rate": "58.13",
                "HR1": "5.05",
                "CI": "1.81-14.09"
            },
            "measures": "[Crude incidence rate, HR1]",
            "outcomes": "[58.13, 5.05]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG-/CagA-",
                "Sample": "205",
                "Cases": "0",
                "Crude incidence rate": "0",
                "HR1": "3.45",
                "CI": "1.38-8.64"
            },
            "measures": "[Crude incidence rate, HR1]",
            "outcomes": "[0, 3.45]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA-",
                "Sample": "143",
                "Cases": "1",
                "Crude incidence rate": "64.61",
                "HR1": "5.50",
                "CI": "0.63-47.57"
            },
            "measures": "[Crude incidence rate, HR1]",
            "outcomes": "[64.61, 5.50]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA+",
                "Sample": "315",
                "Cases": "5",
                "Crude incidence rate": "151.20",
                "HR1": "12.51",
                "CI": "3.57-43.22"
            },
            "measures": "[Crude incidence rate, HR1]",
            "outcomes": "[151.20, 12.51]"
        }
    ],
    "PMC3987090_4": [
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": "\u22641",
                "n": "14",
                "%": "5.6",
                "Median OS": "12.8",
                "95% CI": "0.86\u20133.29",
                "Hazard ratio": "1",
                "P-value": "0.13"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[12.8, 1]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": "\u22641",
                "n": "14",
                "%": "5.6",
                "Hazard ratio": "1",
                "95% CI": "0.69\u20132.71",
                "P-value": "0.37"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": ">1",
                "n": "238",
                "%": "94.4",
                "Median OS": "11.7",
                "95% CI": "",
                "Hazard ratio": "1.68",
                "P-value": "0.13"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[11.7, 1.68]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": ">1",
                "n": "238",
                "%": "94.4",
                "Hazard ratio": "1.37",
                "95% CI": "",
                "P-value": "0.37"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1.37]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": "\u22642",
                "n": "83",
                "%": "32.9",
                "Median OS": "14.8",
                "95% CI": "1.13\u20132.05",
                "Hazard ratio": "1",
                "P-value": "0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[14.8, 1]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": "\u22642",
                "n": "83",
                "%": "32.9",
                "Hazard ratio": "1",
                "95% CI": "0.88\u20131.66",
                "P-value": "0.24"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": ">2",
                "n": "169",
                "%": "67.1",
                "Median OS": "10.7",
                "95% CI": "",
                "Hazard ratio": "1.52",
                "P-value": "0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[10.7, 1.52]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": ">2",
                "n": "169",
                "%": "67.1",
                "Hazard ratio": "1.21",
                "95% CI": "",
                "P-value": "0.24"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1.21]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": "\u22643",
                "n": "158",
                "%": "62.7",
                "Median OS": "13.4",
                "95% CI": "1.26\u20132.23",
                "Hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[13.4, 1]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": "\u22643",
                "n": "158",
                "%": "62.7",
                "Hazard ratio": "1",
                "95% CI": "1.18\u20132.11",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": ">3",
                "n": "94",
                "%": "37.3",
                "Median OS": "8.6",
                "95% CI": "",
                "Hazard ratio": "1.68",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[8.6, 1.68]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": ">3",
                "n": "94",
                "%": "37.3",
                "Hazard ratio": "1.57",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1.57]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": "\u22644",
                "n": "194",
                "%": "77.0",
                "Median OS": "13.3",
                "95% CI": "1.44\u20132.78",
                "Hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[13.3, 1]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": "\u22644",
                "n": "194",
                "%": "77.0",
                "Hazard ratio": "1",
                "95% CI": "1.36\u20132.67",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": ">4",
                "n": "58",
                "%": "23.0",
                "Median OS": "7.3",
                "95% CI": "",
                "Hazard ratio": "2.00",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[7.3, 2.00]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": ">4",
                "n": "58",
                "%": "23.0",
                "Hazard ratio": "1.91",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1.91]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": "\u22645",
                "n": "212",
                "%": "84.1",
                "Median OS": "12.8",
                "95% CI": "1.50\u20133.15",
                "Hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[12.8, 1]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": "\u22645",
                "n": "212",
                "%": "84.1",
                "Hazard ratio": "1",
                "95% CI": "1.49\u20133.15",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Analysis type": "Univariate analysis",
                "NLR threshold": ">5",
                "n": "40",
                "%": "15.9",
                "Median OS": "6.0",
                "95% CI": "",
                "Hazard ratio": "2.17",
                "P-value": "<0.01"
            },
            "measures": "[Median OS, Hazard ratio]",
            "outcomes": "[6.0, 2.17]"
        },
        {
            "subject": {
                "Analysis type": "Multivariate analysis",
                "NLR threshold": ">5",
                "n": "40",
                "%": "15.9",
                "Hazard ratio": "2.16",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[Hazard ratio]",
            "outcomes": "[2.16]"
        }
    ],
    "PMC3987090_5": [
        {
            "subject": {
                "Study": "An X et al.",
                "Year": "2010",
                "n": "89",
                "Number of patients with NLR >5 (%)": "17.9",
                "Overall survival (NLR >5 vs. \u22645) (months)": "2.4 versus 7.7",
                "Hazard ratio (NLR \u22645 was set at 1)": "HR = 4.49, P = 0.013"
            },
            "measures": "[Overall survival (NLR >5 vs. \u22645) (months), Hazard ratio (NLR \u22645 was set at 1)]",
            "outcomes": "[2.4 versus 7.7, HR = 4.49, P = 0.013]"
        },
        {
            "subject": {
                "Study": "Wang DS et al.",
                "Year": "2012",
                "n": "86",
                "Number of patients with NLR >5 (%)": "13.9",
                "Overall survival (NLR >5 vs. \u22645) (months)": "5.8 versus 10.2",
                "Hazard ratio (NLR \u22645 was set at 1)": "NA"
            },
            "measures": "[Overall survival (NLR >5 vs. \u22645) (months)]",
            "outcomes": "[5.8 versus 10.2]"
        },
        {
            "subject": {
                "Study": "Stotz M et al",
                "Year": "2013",
                "n": "261",
                "Number of patients with NLR >5 (%)": "30.3",
                "Hazard ratio (NLR \u22645 was set at 1)": "HR = 2.53, P < 0.01"
            },
            "measures": "[Hazard ratio (NLR \u22645 was set at 1)]",
            "outcomes": "[HR = 2.53, P < 0.01]"
        },
        {
            "subject": {
                "Study": "Our study",
                "Year": "2013",
                "n": "253",
                "Number of patients with NLR >5 (%)": "15.8",
                "Overall survival (NLR >5 vs. \u22645) (months)": "6.0 versus 12.8",
                "Hazard ratio (NLR \u22645 was set at 1)": "HR = 1.95, P < 0.01"
            },
            "measures": "[Overall survival (NLR >5 vs. \u22645) (months), Hazard ratio (NLR \u22645 was set at 1)]",
            "outcomes": "[6.0 versus 12.8, HR = 1.95, P < 0.01]"
        }
    ],
    "PMC3544459_4": [
        {
            "subject": {
                "Condition": "Diabetes",
                "Median survival time (months)": "33.2 \u00b1 1.8",
                "P value (log-rank)": "0.049",
                "HR (95% CI)": "1.0",
                "P": "0.036"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.0, 33.2 \u00b1 1.8]"
        },
        {
            "subject": {
                "Condition": "Diabetes",
                "Median survival time (months)": "24.6 \u00b1 2.5",
                "P value (log-rank)": "0.049",
                "HR (95% CI)": "1.29 (1.02\u20131.64)",
                "P": "0.036"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.27 (1.00\u20131.60), 24.6 \u00b1 2.5]"
        },
        {
            "subject": {
                "Condition": "Perineural invasion",
                "Median survival time (months)": "51.7 \u00b1 31.1",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.0",
                "P": "0.019"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.0, 51.7 \u00b1 31.1]"
        },
        {
            "subject": {
                "Condition": "Perineural invasion",
                "Median survival time (months)": "29.4 \u00b1 1.64",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.60 (1.08\u20132.36)",
                "P": "0.019"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[2.01 (1.38\u20132.93), 29.4 \u00b1 1.64]"
        },
        {
            "subject": {
                "Condition": "Margin status",
                "Median survival time (months)": "33.6 \u00b1 1.7",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.0",
                "P": "0.003"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.0, 33.6 \u00b1 1.7]"
        },
        {
            "subject": {
                "Condition": "Margin status",
                "Median survival time (months)": "24.8 \u00b1 2.6",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.47 (1.14\u20131.90)",
                "P": "0.003"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.62 (1.27\u20132.08), 24.8 \u00b1 2.6]"
        },
        {
            "subject": {
                "Condition": "Node status",
                "Median survival time (months)": "38.6 \u00b1 5.3",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.0",
                "P": "0.002"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.0, 38.6 \u00b1 5.3]"
        },
        {
            "subject": {
                "Condition": "Node status",
                "Median survival time (months)": "27.5 \u00b1 1.3",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.45 (1.14\u20131.83)",
                "P": "0.002"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.70 (1.35\u20132.15), 27.5 \u00b1 1.3]"
        },
        {
            "subject": {
                "Condition": "Differentiation",
                "Median survival time (months)": "35.9 \u00b1 2.68",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.0",
                "P": "<0.001"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.0, 35.9 \u00b1 2.68]"
        },
        {
            "subject": {
                "Condition": "Differentiation",
                "Median survival time (months)": "26.0 \u00b1 1.77",
                "P value (log-rank)": "<0.001",
                "HR (95% CI)": "1.63 (1.32\u20132.02)",
                "P": "<0.001"
            },
            "measures": "[HR (95% CI), Median survival time (months)]",
            "outcomes": "[1.63 (1.32\u20132.02), 26.0 \u00b1 1.77]"
        }
    ],
    "PMC3497287_3": [
        {
            "subject": {
                "Inherited Syndrome": "Lynch Syndrome",
                "Mutated Gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2",
                "Syndrome Type": "Inherited pancreatic cancer syndrome"
            }
        },
        {
            "subject": {
                "Inherited Syndrome": "Peutz-Jeghers Syndrome",
                "Mutated Gene": "STK11/LKB1",
                "Syndrome Type": "Inherited pancreatic cancer syndrome"
            }
        },
        {
            "subject": {
                "Inherited Syndrome": "Hereditary Breast Cancer",
                "Mutated Gene": "BRCA1/BRCA2",
                "Syndrome Type": "Inherited pancreatic cancer syndrome"
            }
        },
        {
            "subject": {
                "Inherited Syndrome": "Familial Atypical Multiple Mole Melanoma",
                "Mutated Gene": "CDKN2A mutation",
                "Syndrome Type": "Inherited pancreatic cancer syndrome"
            }
        }
    ],
    "PMC4728116_3": [
        {
            "subject": {
                "Characteristic": "Family history of pancreatic cancer",
                "Type": "No",
                "Cases": "312",
                "Cases (%)": "-96.6",
                "Controls": "320",
                "Controls (%)": "-99.1",
                "Crude OR": "1.00 (reference)",
                "Adjusted OR1": "1.00 (reference)",
                "Adjusted OR2": "1.00 (reference)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "Characteristic": "Family history of pancreatic cancer",
                "Type": "Yes",
                "Cases": "11",
                "Cases (%)": "-3.4",
                "Controls": "3",
                "Controls (%)": "-0.9",
                "Crude OR": "3.67 (1.02\u201313.14)",
                "Adjusted OR1": "4.04 (1.08\u201315.07)",
                "Adjusted OR2": "1.23 (1.11\u20133.70)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[3.67, 4.04, 1.23]"
        },
        {
            "subject": {
                "Characteristic": "BMI",
                "Type": "<24.0",
                "Cases": "197",
                "Cases (%)": "-61.0",
                "Controls": "230",
                "Controls (%)": "-71.2",
                "Crude OR": "1.00 (reference)",
                "Adjusted OR1": "1.00 (reference)",
                "Adjusted OR2": "1.00 (reference)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "Characteristic": "BMI",
                "Type": "\u226524.0",
                "Cases": "126",
                "Cases (%)": "-39.0",
                "Controls": "93",
                "Controls (%)": "-28.8",
                "Crude OR": "1.67 (1.18\u20132.38)",
                "Adjusted OR1": "1.78 (1.23\u20132.58)",
                "Adjusted OR2": "1.77 (1.22\u20132.57)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.67, 1.78, 1.77]"
        },
        {
            "subject": {
                "Characteristic": "Diabetes",
                "Type": "No",
                "Cases": "174",
                "Cases (%)": "-78.0",
                "Controls": "255",
                "Controls (%)": "-90.7",
                "Crude OR": "1.00 (reference)",
                "Adjusted OR1": "1.00 (reference)",
                "Adjusted OR2": "1.00 (reference)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "Characteristic": "Diabetes",
                "Type": "Yes",
                "Cases": "49",
                "Cases (%)": "-22.0",
                "Controls": "26",
                "Controls (%)": "-9.3",
                "Crude OR": "2.69 (1.51\u20134.77)",
                "Adjusted OR1": "2.60 (1.41\u20134.79)",
                "Adjusted OR2": "2.96 (1.48\u20135.92)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[2.69, 2.60, 2.96]"
        },
        {
            "subject": {
                "Characteristic": "Cholecystitis",
                "Type": "No",
                "Cases": "272",
                "Cases (%)": "-94.1",
                "Controls": "195",
                "Controls (%)": "-96.7",
                "Crude OR": "1.00 (reference)",
                "Adjusted OR1": "1.00 (reference)",
                "Adjusted OR2": "1.00 (reference)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "Characteristic": "Cholecystitis",
                "Type": "Yes",
                "Cases": "17",
                "Cases (%)": "-5.9",
                "Controls": "10",
                "Controls (%)": "-3.3",
                "Crude OR": "1.89 (0.84\u20134.24)",
                "Adjusted OR1": "1.91 (0.83\u20134.38)",
                "Adjusted OR2": "1.35 (0.50\u20133.68)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.89, 1.91, 1.35]"
        },
        {
            "subject": {
                "Characteristic": "Gallstone",
                "Type": "No",
                "Cases": "274",
                "Cases (%)": "-95.1",
                "Controls": "300",
                "Controls (%)": "-98.4",
                "Crude OR": "1.00 (reference)",
                "Adjusted OR1": "1.00 (reference)",
                "Adjusted OR2": "1.00 (reference)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "Characteristic": "Gallstone",
                "Type": "Yes",
                "Cases": "14",
                "Cases (%)": "-4.9",
                "Controls": "5",
                "Controls (%)": "-1.6",
                "Crude OR": "2.80 (1.01\u20137.77)",
                "Adjusted OR1": "2.58 (0.89\u20137.44)",
                "Adjusted OR2": "2.68 (0.65\u201311.07)"
            },
            "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
            "outcomes": "[2.80, 2.58, 2.68]"
        }
    ],
    "PMC4741511_2": [
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy plus sorafenib",
                "LDH": "\u2264 UNR",
                "patients number": "31",
                "patients percentage": "44%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[7.6 months, 12.7 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy plus sorafenib",
                "LDH": "> UNR",
                "patients number": "6",
                "patients percentage": "8%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.8 months, 5.9 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy alone",
                "LDH": "\u2264 UNR",
                "patients number": "27",
                "patients percentage": "38%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[3.3 months, 8.6 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy alone",
                "LDH": "> UNR",
                "patients number": "7",
                "patients percentage": "10%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.2 months, 5.2 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "statistical test": "p-value",
                "p-value": "0.05",
                "metric": "PFS"
            },
            "measures": "[PFS]",
            "outcomes": "[0.05]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "statistical test": "p-value",
                "p-value": "0.0012",
                "metric": "OS"
            },
            "measures": "[OS]",
            "outcomes": "[0.0012]"
        }
    ],
    "PMC5522086_3": [
        {
            "subject": {
                "Upstream Regulator": "Inhibition",
                "Type": "Inhibition"
            },
            "measures": "[ ]",
            "outcomes": "[ ]"
        },
        {
            "subject": {
                "Upstream Regulator": "TP53",
                "Activation z-score": "-2.353",
                "P-value of overlap": "3.34e-32"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.353, 3.34e-32]"
        },
        {
            "subject": {
                "Upstream Regulator": "NUPR1",
                "Log Ratio": "-2.52",
                "Activation z-score": "-3.977",
                "P-value of overlap": "4.62e-13"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[-2.52, -3.977, 4.62e-13]"
        },
        {
            "subject": {
                "Upstream Regulator": "NKX2-3",
                "Activation z-score": "-3.455",
                "P-value of overlap": "5.88e-12"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.455, 5.88e-12]"
        },
        {
            "subject": {
                "Upstream Regulator": "HNF1A",
                "Activation z-score": "-2.359",
                "P-value of overlap": "8.82e-12"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.359, 8.82e-12]"
        },
        {
            "subject": {
                "Upstream Regulator": "CDKN2A",
                "Log Ratio": "1.737",
                "Activation z-score": "-3.219",
                "P-value of overlap": "1.34e-11"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[1.737, -3.219, 1.34e-11]"
        },
        {
            "subject": {
                "Upstream Regulator": "estrogen receptor",
                "Activation z-score": "-2.299",
                "P-value of overlap": "9.57e-10"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.299, 9.57e-10]"
        },
        {
            "subject": {
                "Upstream Regulator": "RB1",
                "Activation z-score": "-4.286",
                "P-value of overlap": "3.74e-08"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-4.286, 3.74e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "TCF3",
                "Activation z-score": "-3.116",
                "P-value of overlap": "4.32e-08"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.116, 4.32e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "TRIM24",
                "Activation z-score": "-3.714",
                "P-value of overlap": "6.26e-07"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.714, 6.26e-07]"
        },
        {
            "subject": {
                "Upstream Regulator": "BCL6",
                "Activation z-score": "-2.313",
                "P-value of overlap": "1.60e-06"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.313, 1.60e-06]"
        },
        {
            "subject": {
                "Upstream Regulator": "NR5A2",
                "Log Ratio": "-2.876",
                "Activation z-score": "-2.7",
                "P-value of overlap": "7.26e-06"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[-2.876, -2.7, 7.26e-06]"
        },
        {
            "subject": {
                "Upstream Regulator": "SATB1",
                "Log Ratio": "-0.814",
                "Activation z-score": "-2.003",
                "P-value of overlap": "1.09e-05"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[-0.814, -2.003, 1.09e-05]"
        },
        {
            "subject": {
                "Upstream Regulator": "IRF4",
                "Log Ratio": "2.115",
                "Activation z-score": "-2.41",
                "P-value of overlap": "4.24e-05"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[2.115, -2.41, 4.24e-05]"
        },
        {
            "subject": {
                "Upstream Regulator": "RBL1",
                "Activation z-score": "-3.124",
                "P-value of overlap": "1.72e-04"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.124, 1.72e-04]"
        },
        {
            "subject": {
                "Upstream Regulator": "SPDEF",
                "Activation z-score": "-2.887",
                "P-value of overlap": "2.39e-04"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.887, 2.39e-04]"
        },
        {
            "subject": {
                "Upstream Regulator": "Activation",
                "Type": "Activation"
            },
            "measures": "[ ]",
            "outcomes": "[ ]"
        },
        {
            "subject": {
                "Upstream Regulator": "STAT3",
                "Activation z-score": "2.924",
                "P-value of overlap": "5.78e-19"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.924, 5.78e-19]"
        },
        {
            "subject": {
                "Upstream Regulator": "CTNNB1",
                "Activation z-score": "3.359",
                "P-value of overlap": "1.99e-15"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.359, 1.99e-15]"
        },
        {
            "subject": {
                "Upstream Regulator": "SP1",
                "Activation z-score": "2.06",
                "P-value of overlap": "4.79e-13"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.06, 4.79e-13]"
        },
        {
            "subject": {
                "Upstream Regulator": "CEBPB",
                "Activation z-score": "2.866",
                "P-value of overlap": "2.62e-12"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.866, 2.62e-12]"
        },
        {
            "subject": {
                "Upstream Regulator": "NFkB (complex)",
                "Activation z-score": "6.314",
                "P-value of overlap": "1.43e-11"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[6.314, 1.43e-11]"
        },
        {
            "subject": {
                "Upstream Regulator": "TBX2",
                "Activation z-score": "4.99",
                "P-value of overlap": "1.62e-11"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[4.99, 1.62e-11]"
        },
        {
            "subject": {
                "Upstream Regulator": "IRF1",
                "Activation z-score": "3.759",
                "P-value of overlap": "2.76e-11"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.759, 2.76e-11]"
        },
        {
            "subject": {
                "Upstream Regulator": "IRF7",
                "Log Ratio": "1.504",
                "Activation z-score": "5.591",
                "P-value of overlap": "2.88e-10"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[1.504, 5.591, 2.88e-10]"
        },
        {
            "subject": {
                "Upstream Regulator": "FOXM1",
                "Log Ratio": "2.152",
                "Activation z-score": "4.395",
                "P-value of overlap": "5.12e-10"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[2.152, 4.395, 5.12e-10]"
        },
        {
            "subject": {
                "Upstream Regulator": "STAT1",
                "Activation z-score": "4.576",
                "P-value of overlap": "2.05e-08"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[4.576, 2.05e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "ETS1",
                "Log Ratio": "0.863",
                "Activation z-score": "2.575",
                "P-value of overlap": "5.06e-08"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[0.863, 2.575, 5.06e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "JUN",
                "Activation z-score": "2.045",
                "P-value of overlap": "5.57e-08"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.045, 5.57e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "FOXO1",
                "Activation z-score": "3.242",
                "P-value of overlap": "9.35e-08"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.242, 9.35e-08]"
        },
        {
            "subject": {
                "Upstream Regulator": "E2F3",
                "Log Ratio": "1.137",
                "Activation z-score": "2.394",
                "P-value of overlap": "1.16e-06"
            },
            "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
            "outcomes": "[1.137, 2.394, 1.16e-06]"
        },
        {
            "subject": {
                "Upstream Regulator": "MBD2",
                "Activation z-score": "2.549",
                "P-value of overlap": "5.41e-06"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.549, 5.41e-06]"
        }
    ],
    "PMC3428781_1": [
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Vitamin A lipid droplets",
                "Value": "Present"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "\u03b1 Smooth muscle actin",
                "Value": "Absent"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Proliferation",
                "Value": "Limited"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Migration",
                "Value": "Limited"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Extracellular matrix production",
                "Value": "Limited"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "Value": "Complement of MMPs and TIMPs to maintain normal ECM turnover"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Production of cytokines",
                "Value": "Limited"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Capacity for phagocytosis",
                "Value": "Absent"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Quiescent PSCs",
                "Characteristic": "Proteomic analyses",
                "Value": "Basal protein expression"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Vitamin A lipid droplets",
                "Value": "Absent"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "\u03b1 Smooth muscle actin",
                "Value": "Present"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Proliferation",
                "Value": "Increased"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Migration",
                "Value": "Increased"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Extracellular matrix production",
                "Value": "Increased"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "Value": "Change in types of MMPs and TIMPs to facilitate ECM deposition"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Production of cytokines",
                "Value": "Increased"
            },
            "measures": "[Cytokines]",
            "outcomes": "[PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Capacity for phagocytosis",
                "Value": "Present"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Cell Type": "Activated PSCs",
                "Characteristic": "Proteomic analyses",
                "Value": "Differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC4941331_3": [
        {
            "subject": {
                "Tumor tissue sample": "Cytoplasmic CDH1 Low",
                "Nuclear HDAC3": "Low and High",
                "Correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[Correlation coefficient]",
            "outcomes": "[0.440]"
        },
        {
            "subject": {
                "Tumor tissue sample": "Cytoplasmic CDH1 High",
                "Nuclear HDAC3": "Low and High",
                "Correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[Correlation coefficient]",
            "outcomes": "[0.440]"
        },
        {
            "subject": {
                "CDH1 expression location": "Membrane",
                "HDAC3 expression location": "Nuclear",
                "Correlation coefficient": "-0.348",
                "P-value": "0.001"
            },
            "measures": "[Correlation coefficient]",
            "outcomes": "[-0.348]"
        },
        {
            "subject": {
                "CDH1 expression location": "Cytoplasmic",
                "HDAC3 expression location": "Nuclear",
                "Correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[Correlation coefficient]",
            "outcomes": "[0.440]"
        }
    ],
    "PMC6062623_3": [
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Right",
                "Density": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.76, 0.002]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Right",
                "Density": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.15, 0.008]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Right",
                "Density": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.25, 0.006]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Right",
                "Density": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.08, 0.009]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Left",
                "Density": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-1.04, 0.32]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Left",
                "Density": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-2.58, 0.022]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Left",
                "Density": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.36, 0.005]"
        },
        {
            "subject": {
                "Hypothesis": "State transition",
                "Graph metric": "Local efficiency",
                "Hemisphere": "Left",
                "Density": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.04, 0.01]"
        }
    ],
    "PMC5464866_2": [
        {
            "subject": {
                "Tissue Type": "Cancerous tissues",
                "Number": "88",
                "FXR Positive": "54 (61.4%)",
                "FXR Negative": "34 (38.6%)"
            },
            "measures": "[FXR Positive, FXR Negative]",
            "outcomes": "[61.4%, 38.6%]"
        },
        {
            "subject": {
                "Tissue Type": "Adjacent tissues",
                "Number": "88",
                "FXR Positive": "27 (30.7%)",
                "FXR Negative": "61 (69.3%)"
            },
            "measures": "[FXR Positive, FXR Negative]",
            "outcomes": "[30.7%, 69.3%]"
        },
        {
            "subject": {
                "FXR Expression": "FXR",
                "Tissue Type": "Cancerous tissues and Adjacent tissues",
                "P Value": "< 0.05"
            },
            "measures": "[FXR Expression]",
            "outcomes": "[ FXR ]"
        }
    ],
    "PMC5687650_6": [
        {
            "subject": {
                "Risk factor": "Gender",
                "Type": "Women or Men",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.175"
            }
        },
        {
            "subject": {
                "Risk factor": "Age",
                "Type": ">65 years or \u226465years",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.163"
            }
        },
        {
            "subject": {
                "Risk factor": "PLR",
                "Type": "high or low",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.660"
            }
        },
        {
            "subject": {
                "Risk factor": "NLR",
                "Type": "high or low",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.969"
            }
        },
        {
            "subject": {
                "Risk factor": "Post/pre-chemotherapy PLR ratio",
                "Type": ">1 or \u22641",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.199"
            }
        },
        {
            "subject": {
                "Risk factor": "Post/pre-chemotherapy NLR ratio",
                "Type": ">1 or \u22641",
                "Analysis": "Univariate analysis",
                "Metric": "P value",
                "Outcome": "0.001"
            }
        },
        {
            "subject": {
                "Risk factor": "Post/pre-chemotherapy NLR ratio",
                "Type": ">1 or \u22641",
                "Analysis": "Multivariate analysis",
                "Metric": "P value",
                "Outcome": "0.001"
            }
        }
    ],
    "PMC5464866_1": [
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Year": "0",
                "Number at risk": "87",
                "Percentage": "49.7%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[87]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Year": "2",
                "Number at risk": "16",
                "Percentage": "9.1%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[16]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Year": "4",
                "Number at risk": "6",
                "Percentage": "3.4%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Year": "6",
                "Number at risk": "1",
                "Percentage": "0.6%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Year": "0",
                "Number at risk": "88",
                "Percentage": "50.3%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[88]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Year": "2",
                "Number at risk": "9",
                "Percentage": "5.1%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[9]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Year": "4",
                "Number at risk": "3",
                "Percentage": "1.7%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Year": "6",
                "Number at risk": "0",
                "Percentage": "0.0%"
            },
            "measures": "[Number at risk]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Median survival time",
                "Unit": "year"
            },
            "measures": "[Median survival time]",
            "outcomes": "[1.83]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Median survival time",
                "Unit": "year"
            },
            "measures": "[Median survival time]",
            "outcomes": "[1.78]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Three year survival rate]",
            "outcomes": "[0.4288]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Lower bound]",
            "outcomes": "[0.3020]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Upper bound]",
            "outcomes": "[0.6089]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Five year survival rate]",
            "outcomes": "[0.3127]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Lower bound]",
            "outcomes": "[0.1776]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "Low",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Upper bound]",
            "outcomes": "[0.5503]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Three year survival rate]",
            "outcomes": "[0.3036]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Lower bound]",
            "outcomes": "[0.1646]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Three year survival rate",
                "Unit": "95% CI"
            },
            "measures": "[Upper bound]",
            "outcomes": "[0.5600]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Five year survival rate]",
            "outcomes": "[0.2277]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Lower bound]",
            "outcomes": "[0.0989]"
        },
        {
            "subject": {
                "Cancer Type": "Pancreatic Cancer",
                "FXR Expression": "High",
                "Metric": "Five year survival rate",
                "Unit": "None"
            },
            "measures": "[Upper bound]",
            "outcomes": "[0.5241]"
        }
    ],
    "PMC5641200_3": [
        {
            "subject": {
                "Adverse Event": "Red blood cells count decreased",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[5 (83), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "Leukopenia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[3 (50), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "Neutropenia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[4 (67), 0]"
        },
        {
            "subject": {
                "Adverse Event": "AST increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 0, 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "ALT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[4 (67), 1 (17), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "GGT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 2 (33)]"
        },
        {
            "subject": {
                "Adverse Event": "Hyponatremia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 0, 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "Nausea",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[3 (50), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Vomiting",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[2 (33), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Diarrhea",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[0, 2 (33)]"
        },
        {
            "subject": {
                "Adverse Event": "Abdominal pain",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Oral mucositis",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "Adverse Event": "Dyspepsia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "Adverse Event": "Dysgeusia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Anorexia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[3 (50), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Alopecia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 4 (67)]"
        },
        {
            "subject": {
                "Adverse Event": "Fatigue",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[3 (50), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Pneumonitis",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G3]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Adverse Event": "Peripheral sensory neuropathy",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "Adverse Event": "Arthralgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[2 (33), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "Myalgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (17), 1 (17)]"
        },
        {
            "subject": {
                "Adverse Event": "LVEF decrease",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G2]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Adverse Event": "Pericardial effusion",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G2]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Adverse Event": "Red blood cells count decreased",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[2 (50), 0]"
        },
        {
            "subject": {
                "Adverse Event": "Leukopenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[2 (50), 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Neutropenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "AST increase",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[4 (100)]"
        },
        {
            "subject": {
                "Adverse Event": "ALT increase",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[3 (75)]"
        },
        {
            "subject": {
                "Adverse Event": "GGT increase",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adverse Event": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Hyponatremia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G3]",
            "outcomes": "[0, 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Nausea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[0, 2 (50)]"
        },
        {
            "subject": {
                "Adverse Event": "Vomiting",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G2, G3]",
            "outcomes": "[0, 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Diarrhea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[1 (25), 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Abdominal pain",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G2]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Oral mucositis",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adverse Event": "Dyspepsia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adverse Event": "Dysgeusia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[0, 1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Anorexia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[0, 2 (50)]"
        },
        {
            "subject": {
                "Adverse Event": "Alopecia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Fatigue",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1, G2]",
            "outcomes": "[0, 3 (75)]"
        },
        {
            "subject": {
                "Adverse Event": "Pneumonitis",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G3]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Peripheral sensory neuropathy",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Arthralgia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G1]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "Adverse Event": "Myalgia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adverse Event": "LVEF decrease",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adverse Event": "Pericardial effusion",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "NCI-CTCAE": "v4.03"
            },
            "measures": "[G2]",
            "outcomes": "[1 (25)]"
        }
    ],
    "PMC5716794_2": [
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "AUC": "0.687",
                "SE": "0.079",
                "CI": "0.575-0.785"
            },
            "measures": "[AUC]",
            "outcomes": "[0.687]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "Sensitivity": "89.1",
                "CI": "78.8-95.5"
            },
            "measures": "[Sensitivity]",
            "outcomes": "[89.1]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "Specificity": "50.0",
                "CI": "26.0-74.0"
            },
            "measures": "[Specificity]",
            "outcomes": "[50.0]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "PPV": "86.4"
            },
            "measures": "[PPV]",
            "outcomes": "[86.4]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "NPV": "56.3"
            },
            "measures": "[NPV]",
            "outcomes": "[56.3]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "55",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "ACC": "80.5"
            },
            "measures": "[ACC]",
            "outcomes": "[80.5]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "AUC": "0.694",
                "SE": "0.077",
                "CI": "0.582-0.791"
            },
            "measures": "[AUC]",
            "outcomes": "[0.694]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "Sensitivity": "90.6",
                "CI": "80.7-96.5"
            },
            "measures": "[Sensitivity]",
            "outcomes": "[90.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "Specificity": "50.0",
                "CI": "26.0-74.0"
            },
            "measures": "[Specificity]",
            "outcomes": "[50.0]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "PPV": "86.6"
            },
            "measures": "[PPV]",
            "outcomes": "[86.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "NPV": "59.9"
            },
            "measures": "[NPV]",
            "outcomes": "[59.9]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "82",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "ACC": "81.7"
            },
            "measures": "[ACC]",
            "outcomes": "[81.7]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "AUC": "0.707",
                "SE": "0.074",
                "CI": "0.596-0.802"
            },
            "measures": "[AUC]",
            "outcomes": "[0.707]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "Sensitivity": "90.6",
                "CI": "80.7-96.5"
            },
            "measures": "[Sensitivity]",
            "outcomes": "[90.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "Specificity": "50.0",
                "CI": "26.0-74.0"
            },
            "measures": "[Specificity]",
            "outcomes": "[50.0]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "PPV": "86.6"
            },
            "measures": "[PPV]",
            "outcomes": "[86.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "NPV": "59.9"
            },
            "measures": "[NPV]",
            "outcomes": "[59.9]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "99",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "ACC": "81.7"
            },
            "measures": "[ACC]",
            "outcomes": "[81.7]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "AUC": "0.731",
                "SE": "0.070",
                "CI": "0.622-0.823"
            },
            "measures": "[AUC]",
            "outcomes": "[0.731]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "Sensitivity": "90.6",
                "CI": "80.7-96.5"
            },
            "measures": "[Sensitivity]",
            "outcomes": "[90.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "Specificity": "50.0",
                "CI": "26.0-74.0"
            },
            "measures": "[Specificity]",
            "outcomes": "[50.0]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "PPV": "86.6"
            },
            "measures": "[PPV]",
            "outcomes": "[86.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "NPV": "59.9"
            },
            "measures": "[NPV]",
            "outcomes": "[59.9]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "134",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "ACC": "81.7"
            },
            "measures": "[ACC]",
            "outcomes": "[81.7]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "AUC": "0.751",
                "SE": "0.067",
                "CI": "0.643-0.840"
            },
            "measures": "[AUC]",
            "outcomes": "[0.751]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "Sensitivity": "89.1",
                "CI": "78.8-95.5"
            },
            "measures": "[Sensitivity]",
            "outcomes": "[89.1]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "Specificity": "55.6",
                "CI": "30.8-78.5"
            },
            "measures": "[Specificity]",
            "outcomes": "[55.6]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "PPV": "87.7"
            },
            "measures": "[PPV]",
            "outcomes": "[87.7]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "NPV": "58.9"
            },
            "measures": "[NPV]",
            "outcomes": "[58.9]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "152",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "ACC": "81.7"
            },
            "measures": "[ACC]",
            "outcomes": "[81.7]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "161",
                "Optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "AUC": "0.756",
                "SE": "0.065",
                "CI": "0.649-0.844"
            },
            "measures": "[AUC]",
            "outcomes": "[0.756]"
        },
        {
            "subject": {
                "Disease": "healthy pancreas",
                "Imaging modality": "diffusion-weighted imaging",
                "ROI size (mm\u00b2)": "161"
            }
        }
    ],
    "PMC3757392_2": [
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Capan-1",
                "ICC": "++",
                "Flow": "40",
                "Confocal": "++",
                "Do": "170"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[++, 40, ++, 170]"
        },
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Cfpac-1",
                "ICC": "+++",
                "Flow": "500",
                "Confocal": "+++",
                "Do": "140"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 500, +++, 140]"
        },
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Panc-1",
                "ICC": "+++",
                "Flow": "80",
                "Confocal": "+++",
                "Do": "160"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 80, +++, 160]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Capan-1",
                "ICC": "++",
                "Flow": "88",
                "Confocal": "++",
                "Do": "190"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[++, 88, ++, 190]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Cfpac-1",
                "ICC": "+++",
                "Flow": "92",
                "Confocal": "+++",
                "Do": "130"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 92, +++, 130]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Panc-1",
                "ICC": "+++",
                "Flow": "91",
                "Confocal": "+++",
                "Do": "170"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 91, +++, 170]"
        },
        {
            "subject": {
                "Vector": "2200-2500",
                "Cell line": "all cells",
                "Do": "2200-2500"
            },
            "measures": "[Do]",
            "outcomes": "[2200-2500]"
        }
    ]
}